Stock screener

HUMA

Conviction 9HealthcareScan · Fri, Jun 26, 2026
Bullish engulfing
HUMA$0.7319+18.05%
ResistanceSupportVol 14Insider buyInsider sellCongress buyCongress sell
63 bars
3
Vol MA14 17.01M
Mar 27Apr 15May 4May 20Jun 9Jun 26
Humacyte, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.humacyte.com ↗
Price0.7319
Change+18.05%
Gap-1.40%
Rel volume1.47×
Avg volume14.31M
Avg $ vol13.58M
SMA 201.11
SMA 500.9880
SMA 2001.17
Price vs 50-25.92%
Price vs 200-37.61%
MA stackbearish
50/200 cross—
Supertrenddown · 1.05
RSI (14)36
MACD hist-0.07
MACD cross—
Stoch %K / %D14 / 7
ADX (14)31
+DI / −DI17 / 30
RSI divergence—
MACD divergence—
ATR %+17.66%
ADR %11.88%
52w high2.73
52w low0.5745
From 52w high-73.19%
Above 52w low+27.40%
New 52w highNo
SqueezeOff
Bollinger width101.28%
%B0.16
Donchian pos13.31%
Donchian high1.53
Donchian low0.6101
AVWAP (52w high)1.22
vs AVWAP high-40.00%
AVWAP (52w low)0.9159
vs AVWAP low-20.09%
OBV trendDown
Chaikin MF (20)-0.34
Today vs 20d1.47×
Avg vol (14d)17.01M
Avg vol (20d)14.31M
Avg $ vol (20d)13.58M
Market cap—
RS 3m (vs SPY)-36.46%
RS 6m (vs SPY)-49.28%
RS line new highNo
Trend template0/8
Technical rank11.7
1 week-20.82%
1 month-36.36%
3 months-5.97%
6 months-35.23%
1 year-66.58%
YTD-24.93%
P/E-3.37
P/B11.84
P/S67.54
P/FCF-1.30
EPS-0.2600
Div yield—
ROE-351.28%
ROA-36.93%
Debt/Eq3.09
Current3.93
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth72.54%
Price target1.96
Target upside216.13%
Analyst ratingBuy
Institutional25.08%
Ent. value124.98M
Revenue495K
Net income-17.62M
Gross profit—
Free cash flow-105.93M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out222.02M
Employees184
ListedFri, Aug 27, 2021
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction9 / 100
Pattern quality—
Tech rank11.7 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish engulfing
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in HUMA · 7 recent

All disclosures →
MemberSideAmount
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-05-03
Sell$1K–$15K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-05-03
Sell$15K–$50K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-04-30
Sell$50K–$100K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-03-21
Buy$1K–$15K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-03-21
Buy$15K–$50K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-02-12
Buy$15K–$50K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-01-19
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in HUMA · 3 buys · 2 sells

InsiderSideShares
Bamforth John Philip
Director · Stock Options (right to buy) · 2026-06-11
Grant80K
Sebelius Kathleen
Director · Common Stock · 2026-05-19
Buy56.82K
Parikh Shamik J
Chief Medical Officer · Common Stock · 2026-05-18
Sell45.89K
Sander Dale A.
CFO and Chief Corp. Dev. Off · Common Stock · 2026-05-18
Sell45.89K
Sander Dale A.
CFO and Chief Corp. Dev. Off · Common Stock · 2026-05-18
Other—
Constantino Michael T.
Director · Common Stock · 2026-05-18
Buy11K

SEC filings

EDGAR filings in HUMA · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.